Intraepithelial squamous cell carcinoma is a type of squamous cell skin cancer that affects the epidermis or the upper layer of the skin. It usually begins in the lower part of the epidermis, but may eventually develop into an invasive squamous cell carcinoma. It most commonly affects the face, neck, legs, and other areas prone to heavy sun exposure. Its main symptom is a flat pink or red scaly lesion with well-defined borders.
Patients with this type of cancer can seek prompt, effective, and cost-efficient treatment in Southeast Asia. The region has many Joint Commission International (JCI)-accredited medical facilities that feature the necessary technology and equipment to accurately diagnose and treat the condition. These hospitals are staffed by licensed and highly qualified dermatologists who specialise in skin cancers and other skin diseases. Many of them have completed their degree or their training in Western countries such as the United States, Canada, Australia, and the United Kingdom, to name a few.
For the diagnosis and treatment of intraepithelial squamous cell carcinoma, many of Southeast Asia’s top dermatologists use an advanced diagnostic procedure called dermatoscopy. Some of the advanced available treatments, on the other hand, include external beam radiotherapy, photodynamic therapy, brachytherapy, and Mohs surgery. All these procedures minimise scarring but can effectively remove the diseased part of the epidermis. These treatments are offered on an outpatient basis, so patients can combine their treatment with a holiday to make the most of their trip. When compared to the cost of the same procedures offered in Western countries, the comprehensive treatment of intraepithelial squamous cell carcinoma is up to 75% cheaper in Southeast Asia. Patients from within Asia, such as those from Indonesia, can save even more on airfare and accommodation, as they don’t have to travel too far to receive Western standard of treatment.